Últimos Artículos de Cardiovascular Diabetology
- Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
- Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
- MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics
- Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study
- Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk
- Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
- Correction to: Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet‑induced obese rats
- Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications
- Correction to: Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet
- Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort
- Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus
- Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
- Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up
- Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
- The predictive utility of circulating PCSK9 levels on diabetes mellitus
- SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
- Prognostic significance of diabetes mellitus in patients with atrial fibrillation
- Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose?
- Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
- Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China